Ethoxzolamide

CAS No. 452-35-7

Ethoxzolamide( L-643786 | PNU-4191 | Redupresin )

Catalog No. M19803 CAS No. 452-35-7

Ethoxzolamide is a carbonic anhydrase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 31 In Stock
10MG 42 In Stock
25MG 65 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ethoxzolamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Ethoxzolamide is a carbonic anhydrase inhibitor.
  • Description
    Ethoxzolamide is a carbonic anhydrase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    L-643786 | PNU-4191 | Redupresin
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Carbonic Anhydrase
  • Recptor
    Carbonic anhydrase
  • Research Area
    Others
  • Indication
    duodenal ulcersglaucoma epilepsy

Chemical Information

  • CAS Number
    452-35-7
  • Formula Weight
    258.32
  • Molecular Formula
    C9H10N2O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:150 mg/mL (580.68 mM) Need ultrasonic and warming
  • SMILES
    CCOc1ccc2nc(sc2c1)S(N)(=O)=O
  • Chemical Name
    6-ethoxy-13-benzothiazole-2-sulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Benjamin K. Johnson et al. The Carbonic Anhydrase Inhibitor Ethoxzolamide Inhibits theMycobacterium tuberculosis PhoPR Regulon and Esx-1 Secretion and Attenuates Virulence. Antimicrob Agents Chemother. 2015 Aug; 59(8): 4436–4445.
molnova catalog
related products
  • SLC-0111

    SLC-0111 is a sulfonamide carbonic anhydrase (CA, EC 4.2.1.1) inhibitor with IC50 of 45 nM and 4.5 nM for tumor-associated enzymes hCA IX and hCA XII.

  • Compound CDy9

    Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.

  • hCAI/II/IV-IN-28

    hCAI/II/IV-IN-28(WAY-638358) is a potent carbonic anhydrase inhibitor with potential anticonvulsant activity.